Blood Collection Needle Manufacturing Plant

Blood Collection Needle Manufacturing Plant Project Report (DPR) Summary:

IMARC Group's comprehensive DPR report, titled "Blood Collection Needle Manufacturing Plant Project Report 2026: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue," provides a complete roadmap for setting up a blood collection needle manufacturing unit. The blood collection needle market is driven by rising diagnostic testing volumes, increasing prevalence of chronic diseases, growing blood donation activities, and rising demand for safe and sterile medical devices. North America accounted for the largest market share of over 41.2% in the global blood collection needle market.

This feasibility report covers a comprehensive market overview to micro-level information, such as unit operations involved, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.

The blood collection needle manufacturing setup cost is provided in detail, covering project economics, capital investments (CapEx), project funding, operating expenses (OpEx), income and expenditure projections, fixed costs vs. variable costs, direct and indirect costs, expected ROI and net present value (NPV), profit and loss account, financial analysis, etc.

Access the Detailed Feasibility Analysis, Request Sample

What is a Blood Collection Needle?

A blood collection needle is a sterile, single-use medical device designed for venipuncture to collect blood samples for diagnostic testing, transfusion, or laboratory analysis. These blood collection needles are typically made of medical-grade stainless steel and attached to plastic hubs or holders compatible with vacuum blood collection tubes. They are available in various gauge sizes to accommodate different patient requirements and clinical applications. Blood collection needles are manufactured under strict sterile and regulatory conditions to ensure patient safety and prevent cross-contamination. Advanced variants include safety-engineered needles with retractable or shielded mechanisms to reduce needlestick injuries among healthcare professionals.

Key Investment Highlights

• Process Used: Stainless steel wire cutting and needle forming, grinding and beveling of needle tips, electropolishing and cleaning, siliconization, plastic hub molding, needle-hub assembly, sterilization, packaging, quality inspection and testing.
• End-use Industries: Hospitals and clinics, diagnostic laboratories, blood banks, ambulatory surgical centers, and home healthcare.
• Applications: Diagnostic blood sampling, blood donation and transfusion, clinical pathology testing, routine health screening, and emergency medical procedures.

Blood Collection Needle Plant Capacity:

The proposed manufacturing facility is designed with an annual production capacity ranging between 100 – 500 Million Units, enabling economies of scale while maintaining operational flexibility.

Blood Collection Needle Plant Profit Margins:

The project demonstrates healthy profitability potential under normal operating conditions. Gross profit margins typically range between 50-60%, supported by stable demand and value-added applications.

• Gross Profit: 50-60%
• Net Profit: 25-35%

Blood Collection Needle Plant Cost Analysis:

The operating cost structure of a blood collection needle manufacturing plant is primarily driven by raw material consumption, particularly stainless steel tube, which accounts for approximately 50-60% of total operating expenses (OpEx).

• Raw Materials: 50-60% of OpEx
• Utilities: 15-20% of OpEx

Financial Projection:

The financial projections for the proposed project have been developed based on realistic assumptions related to capital investment, operating costs, production capacity utilization, pricing trends, and demand outlook. These projections provide a comprehensive view of the project’s financial viability, ROI, profitability, and long-term sustainability.

Major Applications:

• Hospitals and Clinics: Used for routine diagnostic blood draws and inpatient medical testing.
• Diagnostic Laboratories: Essential for sample collection in pathology and clinical testing.
• Blood Banks: Utilized for safe and efficient blood donation procedures.
• Ambulatory Surgical Centers: Applied in preoperative and postoperative testing protocols.
• Home Healthcare: Used in chronic disease monitoring and mobile diagnostic services.

Why Blood Collection Needle Manufacturing?

• Essential medical consumable: High-frequency usage in routine diagnostics ensures consistent demand.
• Rising chronic disease prevalence: Increased testing for diabetes, cardiovascular, and infectious diseases drives usage.
• Strict regulatory compliance ensures quality standards: Manufacturers benefit from structured and standardized production protocols.
• Growing healthcare infrastructure: Expansion of hospitals and labs supports product demand.
• Safety innovation opportunities: Adoption of safety-engineered needles reduces occupational hazards.

Transforming Vision into Reality:

This report provides the comprehensive blueprint needed to transform your blood collection needle manufacturing vision into a technologically advanced and highly profitable reality.

Blood Collection Needle Industry Outlook 2026:

The blood collection needle market is driven by increasing global diagnostic testing volumes and the rising burden of chronic and infectious diseases. For instance, with 3 in 4 American adults living with at least one chronic condition, including over 90% of those aged 65+, more than 75% of adults 35–64, and 60% of adults 18–34, the demand for regular diagnostic testing and medical monitoring remains consistently high. This directly drives sustained growth in the blood collection needle market, as chronic disease management requires frequent blood sampling and laboratory analysis. Growth in preventive healthcare and routine screening programs strengthens demand. Rising blood donation campaigns and transfusion procedures also stimulate consumption. Additionally, regulatory requirements for sterile, single-use medical devices ensure continuous product replacement and recurring demand in clinical settings.

Leading Blood Collection Needle Manufacturers:

Leading manufacturers in the global blood collection needle industry include several multinational companies with extensive production capacities and diverse application portfolios. Key players include:

• Fresenius Kabi AG
• Becton, Dickinson and Company (BD)
• Terumo BCT, Inc.
• Greiner Bio-One International GmbH
• Cardinal Health

all of which serve end-use sectors such as hospitals and clinics, diagnostic laboratories, blood banks, ambulatory surgical centers, and home healthcare.

How to Setup a Blood Collection Needle Manufacturing Plant?

Setting up a blood collection needle manufacturing plant requires evaluating several key factors, including technological requirements and quality assurance.

Some of the critical considerations include:

• Detailed Process Flow: The manufacturing process is a multi-step operation that involves several unit operations, material handling, and quality checks. Below are the main stages involved in the blood collection needle manufacturing process flow:
  • Unit Operations Involved
  • Mass Balance and Raw Material Requirements
  • Quality Assurance Criteria
  • Technical Tests
     
• Site Selection: The location must offer easy access to key raw materials such as stainless steel tubes, plastic hubs, protective caps, and adhesives. Proximity to target markets will help minimize distribution costs. The site must have robust infrastructure, including reliable transportation, utilities, and waste management systems. Compliance with local zoning laws and environmental regulations must also be ensured.​
   
• Plant Layout Optimization: The layout should be optimized to enhance workflow efficiency, safety, and minimize material handling. Separate areas for raw material storage, production, quality control, and finished goods storage must be designated. Space for future expansion should be incorporated to accommodate business growth.​
   
• Equipment Selection: High-quality, corrosion-resistant machinery tailored for blood collection needle manufacturing must be selected. Essential equipment includes needle grinding and beveling machines, CNC forming machines, injection molding machines, assembly automation lines, sterilization chambers, quality testing and inspection systems. All machinery must comply with industry standards for safety, efficiency, and reliability.​
   
• Raw Material Sourcing: Reliable suppliers must be secured for raw materials like stainless steel tubes, plastic hubs, protective caps, and adhesives to ensure consistent production quality. Minimizing transportation costs by selecting nearby suppliers is essential. Sustainability and supply chain risks must be assessed, and long-term contracts should be negotiated to stabilize pricing and ensure a steady supply.
   
• Safety and Environmental Compliance: Safety protocols must be implemented throughout the manufacturing procedure of the blood collection needle. Advanced monitoring systems should be installed to detect leaks or deviations in the process. Effluent treatment systems are necessary to minimize environmental impact and ensure compliance with emission standards.​
   
• Quality Assurance Systems: A comprehensive quality control system should be established throughout production. Analytical instruments must be used to monitor product concentration, purity, and stability. Documentation for traceability and regulatory compliance must be maintained.

Project Economics:

​Establishing and operating a blood collection needle manufacturing plant involves various cost components, including:​

• Capital Investment: The total capital investment depends on plant capacity, technology, and location. This investment covers land acquisition, site preparation, and necessary infrastructure.
   
• Equipment Costs: Equipment costs, such as those for needle grinding and beveling machines, CNC forming machines, injection molding machines, assembly automation lines, sterilization chambers, quality testing and inspection systems, represent a significant portion of capital expenditure. The scale of production and automation level will determine the total cost of machinery.​
   
• Raw Material Expenses: Raw materials, including core ingredients like stainless steel tubes, plastic hubs, protective caps, and adhesives, are a major part of operating costs. Long-term contracts with reliable suppliers will help mitigate price volatility and ensure a consistent supply of materials.​
   
• Infrastructure and Utilities: Costs associated with land acquisition, construction, and utilities (electricity, water, steam) must be considered in the financial plan.
   
• Operational Costs: Ongoing expenses for labor, maintenance, quality control, and environmental compliance must be accounted for. Optimizing processes and providing staff training can help control these operational costs.​
   
• Financial Planning: A detailed financial analysis, including income projections, expenditures, and break-even points, must be conducted. This analysis aids in securing funding and formulating a clear financial strategy. 

Capital Expenditure (CapEx) and Operational Expenditure (OpEx) Analysis:

Capital Investment (CapEx): Machinery costs account for the largest portion of the total capital expenditure. The cost of land and site development, including charges for land registration, boundary development, and other related expenses, forms a substantial part of the overall investment. This allocation ensures a solid foundation for safe and efficient plant operations.

Operating Expenditure (OpEx): In the first year of operations, the operating cost for the blood collection needle manufacturing plant is projected to be significant, covering raw materials, utilities, depreciation, taxes, packing, transportation, and repairs and maintenance. By the fifth year, the total operational cost is expected to increase substantially due to factors such as inflation, market fluctuations, and potential rises in the cost of key materials. Additional factors, including supply chain disruptions, rising consumer demand, and shifts in the global economy, are expected to contribute to this increase.

Capital Expenditure Breakdown:

To access CapEx Details, Request Sample

Operational Expenditure Breakdown:

To access OpEx Details, Request Sample

Profitability Analysis: 

To access Financial Analysis, Request Sample

Latest Industry Developments:

• December 2025: Hims & Hers Health, Inc. acquired YourBio Health, Inc. Through the integration of YourBio’s advanced blood collection devices, Hims & Hers aims to transform and modernize the blood sampling process, advancing toward a new standard centered on convenient and pain-free blood collection.
   
• December 2024: Metropolis Healthcare Limited launched the UltraTouch Push Button Blood Collection Set (PBBCS) across its network. Featuring a thinner needle, the device is designed to minimize discomfort during blood draws, particularly for first-time patients, children, and elderly individuals. In addition to improving patient comfort, the PBBCS is intended to enhance the overall speed, safety, and efficiency of the blood collection process.

Report Coverage:

Report Customization

While we have aimed to create an all-encompassing blood collection needle manufacturing plant project report, we acknowledge that individual stakeholders may have unique demands. Thus, we offer customized report options that cater to your specific requirements. Our consultants are available to discuss your business requirements, and we can tailor the report's scope accordingly. Some of the common customizations that we are frequently requested to make by our clients include:

• The report can be customized based on the location (country/region) of your plant.
• The plant’s capacity can be customized based on your requirements.
• Plant machinery and costs can be customized based on your requirements.
• Any additions to the current scope can also be provided based on your requirements.

Why Buy IMARC Reports?

• The insights provided in our reports enable stakeholders to make informed business decisions by assessing the feasibility of a business venture.
• Our extensive network of consultants, raw material suppliers, machinery suppliers and subject matter experts spans over 100+ countries across North America, Europe, Asia Pacific, South America, Africa, and the Middle East.
• Our cost modeling team can assist you in understanding the most complex materials. With domain experts across numerous categories, we can assist you in determining how sensitive each component of the cost model is and how it can affect the final cost and prices.
• We keep a constant track of land costs, construction costs, utility costs, and labor costs across 100+ countries and update them regularly.
• Our client base consists of over 3000 organizations, including prominent corporations, governments, and institutions, who rely on us as their trusted business partners. Our clientele varies from small and start-up businesses to Fortune 500 companies.
• Our strong in-house team of engineers, statisticians, modeling experts, chartered accountants, architects, etc. has played a crucial role in constructing, expanding, and optimizing sustainable manufacturing plants worldwide.